Loomis, Sayles & Company’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $222K | Buy |
|
|||||
|
2025
Q1 | $212K | Buy |
|
|||||
|
2024
Q4 | $148K | Sell |
|
|||||
|
2024
Q3 | $245K | Buy |
|
|||||
|
2024
Q2 | $220K | Sell |
|
|||||
|
2024
Q1 | $220K | Sell |
|
|||||
|
2023
Q4 | $232K | Sell |
|
|||||
|
2023
Q3 | $290K | Sell |
|
|||||
|
2023
Q2 | $722K | Sell |
|
|||||
|
2023
Q1 | $838K | Sell |
|
|||||
|
2022
Q4 | $1.35M | Buy |
|
|||||
|
2022
Q3 | $682K | Buy |
|
|||||
|
2022
Q2 | $414K | Sell |
|
|||||
|
2022
Q1 | $1.36M | Sell |
|
|||||
|
2021
Q4 | $1.99M | Sell |
|
|||||
|
2021
Q3 | $1.75M | Sell |
|
|||||
|
2021
Q2 | $1.78M | Buy |
|
|||||
|
2021
Q1 | $1.53M | Buy |
|
|||||
|
2020
Q4 | $40K | Sell |
|
|||||
|
2020
Q3 | $237K | Sell |
|
|||||
|
2020
Q2 | $267K | Sell |
|
|||||
|
2020
Q1 | $664K | Sell |
|
|||||
|
2019
Q4 | $2.5M | Buy |
|
|||||
|
2019
Q3 | $313K | Sell |
|
|||||
|
2019
Q2 | $5.07M | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $317K | Sell |
|
|||||
|
2018
Q3 | $3.79M | Sell |
|
|||||
|
2018
Q2 | $13.5M | Sell |
|
|||||
|
2018
Q1 | $22.1M | Sell |
|
|||||
|
2017
Q4 | $64.8M | Sell |
|
|||||
|
2017
Q3 | $96M | Sell |
|
|||||
|
2017
Q2 | $100M | Sell |
|
|||||
|
2017
Q1 | $107M | Buy |
|
|||||
|
2016
Q4 | $95.7M | Sell |
|
|||||
|
2016
Q3 | $109M | Sell |
|
|||||
|
2016
Q2 | $118M | Buy |
|
|||||
|
2016
Q1 | $90.5M | Buy |
|
|||||
|
2015
Q4 | $75.2M | Sell |
|
|||||
|
2015
Q3 | $79.2M | Sell |
|
|||||
|
2015
Q2 | $96.4M | Sell |
|
|||||
|
2015
Q1 | $111M | Sell |
|
|||||
|
2014
Q4 | $115M | Sell |
|
|||||
|
2014
Q3 | $122M | Sell |
|
|||||
|
2014
Q2 | $123M | Sell |
|
|||||
|
2014
Q1 | $163M | Sell |
|
|||||
|
2013
Q4 | $161M | Buy |
|
|||||
|
2013
Q3 | $148M | Sell |
|
|||||
|
2013
Q2 | $175K | Buy |
|